STOCK TITAN

National Research Corporation Announces Quarterly Dividend and Stock Repurchase Authorization

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
buyback dividends
Rhea-AI Summary

NRC Health announced a quarterly cash dividend of $0.24 per share payable on July 15, 2022, to shareholders on record by June 30, 2022. Additionally, the Board of Directors approved a new stock repurchase authorization of up to 2.5 million shares. This buyback will occur based on market conditions and corporate considerations. The previous repurchase authorization has concluded, and the new one has no expiration date, reflecting NRC Health's commitment to enhancing shareholder value.

Positive
  • Quarterly dividend of $0.24 per share enhances shareholder returns.
  • New stock repurchase authorization of up to 2.5 million shares may boost stock value.
Negative
  • None.

Lincoln, Nebraska, May 20, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health (the “Company”), (NASDAQ:NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.24 (twenty-four cents) per share payable Friday, July 15, 2022, to shareholders of record as of the close of business on Thursday, June 30, 2022.

Also, on May 19, 2022, the Company’s Board of Directors approved a new stock repurchase authorization of up to 2.5 million shares of its common stock. The Company is authorized to repurchase from time-to-time shares of its outstanding common stock on the open market or in privately negotiated transactions. The timing and amount of stock repurchases will depend on a variety of factors, including market conditions as well as corporate and regulatory considerations. The stock repurchase authorization may be suspended, modified, or discontinued at any time and the Company has no obligation to repurchase any amount of its common stock in connection with the repurchase authorization. The repurchase authorization has no set expiration date. The new authorization follows the Company’s recent repurchase of all shares remaining under the Board’s previous repurchase authorization.

For more than 40 years, NRC Health has been committed to achieving Human Understanding and bringing healthcare organizations closer to their customers than ever before by illuminating and improving the key moments that define an experience and build trust. Guided by their uniquely empathic heritage, proprietary methods, skilled associates, and holistic approach, NRC Health helps its customers design experiences that exceed expectations, inspire loyalty, and improve well-being among patients, residents, physicians, nurses, and staff.


FAQ

What is the dividend amount declared by NRC Health?

NRC Health declared a quarterly cash dividend of $0.24 per share.

When will the NRC Health dividend be paid?

The dividend will be paid on July 15, 2022.

What is the purpose of NRC Health's stock repurchase authorization?

The stock repurchase aims to enhance shareholder value and manage stock supply.

How many shares can NRC Health repurchase under the new authorization?

NRC Health can repurchase up to 2.5 million shares of its common stock.

Is there an expiration date for NRC Health's stock repurchase authorization?

No, the new stock repurchase authorization has no set expiration date.

National Research Corporation

NASDAQ:NRC

NRC Rankings

NRC Latest News

NRC Stock Data

403.08M
14.70M
37.38%
52.04%
1.46%
Health Information Services
Services-commercial Physical & Biological Research
Link
United States of America
LINCOLN